Cooperative Recognition of Internationally Disseminated Ceftriaxone-Resistant Neisseria gonorrhoeae Strain

Ceftriaxone remains a first-line treatment for patients infected by Neisseria gonorrhoeae in most settings. We investigated the possible spread of a ceftriaxone-resistant FC428 N. gonorrhoeae clone in Japan after recent isolation of similar strains in Denmark (GK124) and Canada (47707). We report 2...

Full description

Saved in:
Bibliographic Details
Published inEmerging infectious diseases Vol. 24; no. 4; pp. 735 - 740
Main Authors Lahra, Monica M., Martin, Irene, Demczuk, Walter, Jennison, Amy V., Lee, Ken-Ichi, Nakayama, Shu-Ichi, Lefebvre, Brigitte, Longtin, Jean, Ward, Alison, Mulvey, Michael R., Wi, Teodora, Ohnishi, Makoto, Whiley, David
Format Journal Article
LanguageEnglish
Published United States U.S. National Center for Infectious Diseases 01.04.2018
Centers for Disease Control and Prevention
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Ceftriaxone remains a first-line treatment for patients infected by Neisseria gonorrhoeae in most settings. We investigated the possible spread of a ceftriaxone-resistant FC428 N. gonorrhoeae clone in Japan after recent isolation of similar strains in Denmark (GK124) and Canada (47707). We report 2 instances of the FC428 clone in Australia in heterosexual men traveling from Asia. Our bioinformatic analyses included core single-nucleotide variation phylogeny and in silico molecular typing; phylogenetic analysis showed close genetic relatedness among all 5 isolates. Results showed multilocus sequence type 1903; N. gonorrhoeae sequence typing for antimicrobial resistance (NG-STAR) 233; and harboring of mosaic penA allele encoding alterations A311V and T483S (penA-60.001), associated with ceftriaxone resistance. Our results provide further evidence of international transmission of ceftriaxone-resistant N. gonorrhoeae. We recommend increasing awareness of international spread of this drug-resistant strain, strengthening surveillance to include identifying treatment failures and contacts, and strengthening international sharing of data.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1080-6040
1080-6059
1080-6059
DOI:10.3201/eid2404.171873